Fund Holdings — FCPM III SERVICES B.V.

Total Portfolio Value:
$413.71M
Total Bought:
$53.77M
Total Sold:
$12.71M
Net Transaction:
+$41.06M
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Newamsterdam Pharma Company
ORDINARY SHARES
10,597,18110,935,310+338,129$272.35M$223.85M54.11%-$48.50M
Dyne Therapeutics, Inc.(DYN)5,462,8465,462,8460$128.70M$57.14M13.81%-$71.56M
Engene Holdings Inc
COM
9,632,5619,632,5610$64.06M$43.15M10.43%-$20.90M
Replimune Group, Inc.(REPL)3,970,6683,909,696-60,972$48.08M$38.12M9.21%-$9.97M
Bicycle Therapeutics PlcADS3,452,3303,452,3300$48.33M$29.31M7.08%-$19.02M
Astria Therapeutics Inc2,872,5373,822,537+950,000$25.68M$20.41M4.93%-$5.27M
Engene Holdings IncW EXP 10 31 2028
*W EXP 10/31/202
2,878,1482,878,1480$2.43M$1.73M0.42%-$699.1K
Achilles Therapeutics PlcADS2,390,0500-2,390,050$2.75M$0—-$2.75M
Page 1 of 1